Vitelliform Macular Dystrophy, also known as Best disease in its early-onset form, is a rare genetic eye disorder that primarily affects the macula, the central part of the retina responsible for sharp, detailed vision. This condition is characterized by the abnormal buildup of a fatty yellow pigment called lipofuscin in the cells underlying the macula. Over time, this accumulation can damage the light-sensitive cells, leading to progressive vision loss.
There are two main forms of this condition: early-onset (Best disease) and adult-onset. Best disease typically appears in childhood or adolescence, while the adult-onset form usually begins in mid-adulthood. Both forms share similar features, including the characteristic yellow, egg yolk-like lesions in the macula that can be detected during a comprehensive eye examination.
Symptoms of Vitelliform Macular Dystrophy often start with blurred or distorted central vision. Patients may find it increasingly difficult to perform tasks that require fine detail, such as reading, driving, or recognizing faces. Importantly, this condition typically does not affect peripheral (side) vision or the ability to see at night, allowing most individuals to maintain a significant degree of independence.
The progression of the disease varies widely among individuals. In Best disease, the condition often progresses through several stages, starting with a normal-appearing macula, followed by the development of the vitelliform (egg yolk) lesion, and eventually leading to a "scrambled egg" appearance as the lesion breaks down. This final stage is often associated with more significant vision loss.
Diagnosis usually involves a combination of clinical examination, imaging tests like Optical Coherence Tomography (OCT), and specialized tests such as an electro-oculogram (EOG), which measures the electrical activity of the eye and is characteristically abnormal in Best disease. Genetic testing can also confirm the diagnosis by identifying mutations in the associated genes.
While there is currently no cure for Vitelliform Macular Dystrophy, regular monitoring by an eye care professional is crucial. Patients should consult their healthcare provider to discuss their specific symptoms and management plan.